NVCT- Nuvectis Pharma, Inc.

Name: Nuvectis Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bentsur Ron	3.68M	$71.94M	-
10%	Mosseri Marlio Charles	3.14M	$61.38M	-
Other	Poradosu Enrique	1.81M	$35.35M	-
Other	Shemesh Shay	1.79M	$35.09M	-
VP	Carson Michael J.	200.1K	$3.92M	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 16, 2023	Bentsur Ron64	Chairman &CEO	Buy	320	$17.03	$5,448.00	-	-11.5%	-60.7%
Mar 27, 2023	Poradosu Enrique70	Chief Science &Business Off	Buy	500	$11.55	$5,775.00	-	+37.3%	-31.1%
Mar 23, 2023	Bentsur Ron64	Chairman &CEO	Buy	230	$12.13	$2,789.90	-	+46.2%	-25.7%
Mar 21, 2023	Bentsur Ron64	Chairman &CEO	Buy	480	$12.08	$5,798.40	-	+45.6%	-29.2%
Mar 21, 2023	Shemesh Shay72	Chief Dev. &Ops. Officer	Buy	420	$11.99	$5,035.80	-	+45.6%	-29.2%
Mar 15, 2023	Shemesh Shay72	Chief Dev. &Ops. Officer	Buy	670	$10.71	$7,175.70	-	+67.9%	-16.5%
Mar 15, 2023	Bentsur Ron64	Chairman &CEO	Buy	2,160	$10.86	$23,464.80	-	+67.9%	-16.5%
Dec 21, 2022	Shemesh Shay72	Chief Dev. &Ops. Officer	Buy	500	$7.65	$3,825.00	-	+68.2%	+9.8%
Nov 30, 2022	Bentsur Ron64	Chairman &CEO	Buy	150	$7.45	$1,117.50	-	+55.5%	+15.6%
Nov 29, 2022	Bentsur Ron64	Chairman &CEO	Buy	450	$7.41	$3,334.50	-	+51.9%	+12.2%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC